Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...
AI-driven tools harness ML algorithms to provide insights into anxiety disorders. Supervised ML models, such as logistic ...
Calming exercises can help tame anxiety, but a creative life is a cure-all according to author Martha Beck: “Anxiety can’t ...
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.
A study out of the University of Minnesota has revealed that kids who face various forms of exclusionary discipline (ED) at school were at greater risk of developing anxiety and depression. The ...
“Hyperthyroidism is often linked to Graves’ disease, another autoimmune condition that overstimulates the thyroid. Thyroid nodules, which are abnormal lumps in the thyroid, and excessive iodine can ...
Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on Mind Medicine (MNMD – Research Report). The associated price ...
A new study from the Texas A&M University School of Public Health provides additional evidence that meditation using ...
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under ...
Shortness of breath, or dyspnea, is an anxiety symptom that can be triggered by certain, anxiety-inducing situations. Here’s ...
Mind Medicine (MNMD) announced that the first patient has been dosed in Panorama, its second Phase 3 study evaluating MM120 ODT, a proprietary, ...